ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

AVO Advanced Oncotherapy Plc

1.925
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Advanced Oncotherapy Plc LSE:AVO London Ordinary Share GB00BD6SX109 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1.925 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Medical Laboratories 0 -29.49M -0.0549 -0.35 10.32M
Advanced Oncotherapy Plc is listed in the Medical Laboratories sector of the London Stock Exchange with ticker AVO. The last closing price for Advanced Oncotherapy was 1.93p. Over the last year, Advanced Oncotherapy shares have traded in a share price range of 1.875p to 8.50p.

Advanced Oncotherapy currently has 537,481,209 shares in issue. The market capitalisation of Advanced Oncotherapy is £10.32 million. Advanced Oncotherapy has a price to earnings ratio (PE ratio) of -0.35.

Advanced Oncotherapy Share Discussion Threads

Showing 5526 to 5550 of 5650 messages
Chat Pages: 226  225  224  223  222  221  220  219  218  217  216  215  Older
DateSubjectAuthorDiscuss
24/3/2023
19:10
I’m not so sure, I’m not sure where the next glut of finances come from, especially as there are no clear roads to profitability without significant risk.
danmart2
24/3/2023
08:57
I understand your concerns but we all have to make our own decisions how we react, based on our personal knowledge and experience and what risk we are prepared to take. I've been here before with AVO. I'm fairly sanguine about the situation and regard the chart as an irrelevant distraction.

The worst that can happen is that AVO won't have enough cash to get us over the finishing line to commercialisation. If it survives, which I believe it will, I expect to make a profit. Perhaps a very large profit. If AVO is taken over by another company I still hope to make a profit.

LIGHT is going to totally overturn the world of cancer treatment, no matter who owns it. There is absolutely no doubt about that.

daijavu
23/3/2023
21:32
I am not sure how to answer Have you seen the chart There is nothing further to say
value viper
23/3/2023
21:28
What is your point? Do you think it makes AVO less investible?
daijavu
23/3/2023
20:37
So his shares are currently worth £12k His has earned over a million quid I recall per annum in previous years - basic until recent was £300k Totally ridiculous He hasn't ever bought a share to my knowledge
value viper
23/3/2023
10:15
Is it worth shortening this stock?

It must have further to fall , serious risk of collapse without more funding and no sign of income

danmart2
23/3/2023
08:30
He has owned 416,667 shares since 10 Aug 2021 and there's no record of him having ever sold any
daijavu
22/3/2023
18:20
CEO has never bought a share to my knowledge
value viper
16/3/2023
08:38
The BoD might be cack handed but I think they all have to much to lose to let AVO go under. As long as AVO manages to survive as an independent entity we should all do very well in the long term. If it's bought out by a rival wanting to get their hands on LIGHT we should get a good price, especially if there's a bidding war. This year could be the turning point.

Just my opinion, of course

daijavu
06/3/2023
09:38
Thanks for the summary of Figs PJ.

Unfortunately my first buy was much higher than 40p. But if it comes good, my average will well cover the higher losses.

Not for the first time, they have tarnished great scientific endeavour, by incompetent/naive financial management.

I think we are in cross your fingers tightly territory, so hope dilution doesn't wipe us out. In one sense good that directors are holding a lot, but will probably also benefit them more when the next diluting fund raise arises.

I guess we'll see...

gerhart
05/3/2023
01:00
Amen to that.

Good luck all.

daijavu
03/3/2023
19:50
Gerhart my average is just under 26p and given that I am showing an 80% loss it seems almost as stupid as your 40p, however I doubt there are many current holders not showing big losses.

I am also very concerned by the recent RNS's and the implications for funding but agree the fact they still are including the exercise price of the warrants as 25p does give rise to some hope, however small, that they see a realistic chance of it returning to a price above that.

The only other thing that gives a small amount of comfort is that the directors holdings are considerably larger than mine and I suspect larger than most private investors, so at least they are well aware of the pain we are experiencing and have quite an incentive to turn it around.

Liquid Harmony Limited* 45,757,097 8.51%
Michael Sinclair and Family 9,440,814 1.76%
Mr Michael S Bradfield 8,354,240 1.55%
Dr P N Plowman 4,675,304 0.87%
Dr Enrico C Vanni 4,076,361 0.76%
Mr Nicolas Serandour 2,177,134 0.41%
Mr Steve Myers 1,540,569 0.29%
Mr Hans Van Celsing 982,499 0.18%
Mrs Lori Cross 293,749 0.06%

* This holding includes shares held by Mrs. RenHua Zhang and associated partners.

The science and opportunity all seems to be moving in the right direction. Let's hope we can get there.

pj84
02/3/2023
09:55
I'm in at a much higher price. Bought some, at what now seems a completely stupid level. Then plenty more around 40p.

But I can't say the warning signals weren't there to enable me to get out at a loss before this level. ...the constant, almost monthly, passing around of the hat, raising more funds, with no clear long term financial plan provided. Then the inevitable, perhaps unavoidable, tech delays.

Yesterday's announcement still has a "headline" of 25p. So perhaps whatever way things work out, that will be the guide to final fundraising, so may see the share price return to at least that level in due course. We'll see.

First human due to be treated in later this year. And with them so far down the road, I agree with others, though poor business managers, good medics/scientists. So I think we'll make it through. Just how bad will any "dilution" be? We'll see in due course the plans.

gerhart
02/3/2023
08:29
I agree twirl. The BoD may be brilliant and highly respected scientists they're rubbish at running a business. As for relating to shareholders, they're not even in the same universe as us. We don't exist as far as they're concerned unless we cause problems such as with the share price.

If it wasn't for the technology, I wouldn't touch AVO with a bargepole.

daijavu
01/3/2023
19:38
nervous few months ahead , any more set backs could be terminal
danmart2
01/3/2023
18:57
twirl, I think you called me 'altruistic' back in 2017 when I suggested all was far from well. Seems the same is true today. Wrong management. Scientists! (and still not open)

waterloo01 - 18 Jul 2017 - 18:29:56 - 3522 of 4971 Advanced Oncotherapy (AVO) - formerly CareCapital - AVO
Wrong people running this as has been the case for a long time. Good science/bad business. Evans wasn't the 1st red flag but the video of the demolition block, might be the last before the inevitable. To think they raised at £1.00 not that long ago. At least the BOD are also heavily invested.

waterloo01
01/3/2023
17:36
par555>> omens are bad - really bad and Tom Winnifreth has done a bearcast (which has a paywall) but bound to be negative.

I hope something can be salvaged for all the LTH - apart from the Board who have led investors up the garden path.

twirl
01/3/2023
16:56
Long term holder of a few of these patiently waiting for the 'jam tomorrow' to arrive. I see the interest rate on these is 1.25% per month = 15% p.a ! seems a bit desperate
to me.

par555
01/3/2023
15:39
There goes much of any future revenue from Harley St and sill only funded till April.
waterloo01
01/3/2023
15:02
So they have done some financing for now and the headline again is 25p.....

But talk of "cash runways" speaks of very poor management/planning. It will limit future options and the costs of the those options. Higher rate for any loan and perhaps greater dilution. Assuming it works out!

gerhart
01/3/2023
14:57
I haven't invested, and lost, based on any imaging function of proton beams, but replacing radiotherapy using x-rays is something that could happen if costs oome down, which LIGHT can do.
Yes, a bit depressing at the moment, to say the least!

gclark
01/3/2023
12:04
Kinwah. I'm not a scientist but I read science papers. It has been known for a long time that proton beams have the potential to be used for imaging. The only reason they haven't has been the limited availability of proton technology and the cost of using what is available. The same goes for using proton beams to treat adults with cancer.
daijavu
01/3/2023
11:55
Daijavu, you are one heck of an optimist but clearly not a scientist. Proton beams are used to kill cancers not for imaging. Protons are much gentler on the patient compared to x-rays which is why the main uses so far have been on children's brain tumours. One big question is whether radiologists will want to use proton beams to treat adults with more common forms of cancer or stick with more powerful (and potentially harmful) x-rays.
kinwah
01/3/2023
11:10
At end of Dec most/all key directors bought shares around 12p. Just a few weeks later they issue financial plans. Share price goes on major slide.

So did the directors buy, knowing any placing/rights (along with any financial loans) will be well above 12p.

Or did they buy to give the impression, that they were suffering too, knowing share price would take a hit on speculation once the plans were announced - which they must have known general intentions when they bought.

I think and hope it is the former. All those big investors that stumped up big sums previously must have known the long term risk/plans for final funds to bring Tech to fruition. So wouldn't have stumped-up just to watch their investment collapse.

So this share price slide is due to negative speculation only? That's my hope.

(happened, justifiably, before when they got into the death spiral shares for loans. Shares dumped. Price fell. Even greater shares for loans. Shares dumped, price fell...etc etc. Then they changed track, and their was massive spike)

gerhart
01/3/2023
08:08
It's nothing new. I've been here before with AVO.

On the other hand, with the right company LIGHT could be a gamechanger way beyond even the treatment of cancer. Much safer proton beams have the potential to replace X-ray imaging in every conceivable situation. The only limiting factor up until now has been the cost and size of cyclotrons. LIGHT has the potential to change all that.

With a competent BoD in charge of AVO we might even imagine a future in which proton beams replace x-ray imaging in every hospital, doctors' surgery and dentists' clinic throughout the world. All the equipment bearing the AVO logo.

daijavu
Chat Pages: 226  225  224  223  222  221  220  219  218  217  216  215  Older

Your Recent History

Delayed Upgrade Clock